Outcome of Lamellar Graft Patching for the Treatment of Noninfectious Corneal Perforations.


Journal

Cornea
ISSN: 1536-4798
Titre abrégé: Cornea
Pays: United States
ID NLM: 8216186

Informations de publication

Date de publication:
01 Sep 2022
Historique:
received: 12 05 2021
accepted: 14 09 2021
pubmed: 24 11 2021
medline: 11 8 2022
entrez: 23 11 2021
Statut: ppublish

Résumé

The aims of this study were to evaluate the clinical outcome of lamellar graft patching used for treating noninfectious corneal perforations and to determine the clinical factors affecting tectonic integrity. This retrospective study includes a total of 71 eyes of 67 patients who underwent lamellar graft patching for the treatment of corneal perforations due to persistent epithelial defects secondary to limbal stem cell deficiency (LSCD, 21 eyes; 29.6%), peripheral ulcerative keratitis (17 eyes; 23.9%), neurotrophic keratitis due to herpes simplex keratitis (HSK, 14 eyes; 19.7%), and other causes (19 eyes; 26.8%). We evaluated the tectonic integrity of the globe, visual outcomes, and postoperative complications. Tectonic integrity was achieved in 53 eyes (74.6%). The survival proportions of eyes that achieved clear grafts were 77.8% and 65.2% at 12 and 24 months, respectively. Graft failure was observed in 19 eyes (26.8%). The survival rate of tectonic integrity and eyes that finally achieved a clear graft was significantly worse in eyes with LSCD compared with those without ( P < 0.001). The logarithm of minimal angle resolution improved significantly from 1.79 ± 0.98 to 1.22 ± 0.87 at 12 months and 1.08 ± 0.81 at 24 months. Postoperative complications included cataract formation (32 eyes, 45.1%), intraocular pressure rise (23 eyes, 32.4%), recurrent perforations (15 eyes, 21.1%), infectious keratitis (14 eyes, 19.7%), recurrence of herpes simplex keratitis (7 eyes, 9.9%), and traumatic graft dehiscence (1 eye, 1.4%). Lamellar graft patching is an effective and safe surgical treatment for noninfectious corneal perforations; however, careful attention to severe complications is necessary, especially in eyes with LSCD.

Identifiants

pubmed: 34812781
doi: 10.1097/ICO.0000000000002926
pii: 00003226-202209000-00009
pmc: PMC9365251
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1122-1128

Informations de copyright

Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc.

Déclaration de conflit d'intérêts

The authors have no funding or conflicts of interest to disclose.

Références

Yin J, Singh RB, Al Karmi R, et al. Outcomes of cyanoacrylate tissue adhesive application in corneal thinning and perforation. Cornea. 2019;38:668–673.
Korah S, Selvin SS, Pradhan ZS, et al. Tenons patch graft in the management of large corneal perforations. Cornea. 2016;35:696–699.
Grau AE, Durán JA. Treatment of a large corneal perforation with a multilayer of amniotic membrane and TachoSil. Cornea. 2012;31:98–100.
Croghan C, Chou CY, Gajree S, et al. Emergency therapeutic penetrating keratoplasty in a tertiary ophthalmic care facility. Eye (Lond). 2018;32:655–657.
Hanada K, Igarashi S, Muramatsu O, et al. Therapeutic keratoplasty for corneal perforation: clinical results and complications. Cornea. 2008;27:156–160.
Koçluk Y, Sukgen EA. Results of therapeutic penetrating keratoplasty for bacterial and fungal keratitis. Int Ophthalmol. 2017;37:1085–1093.
Mannan R, Sharma N, Pruthi A, et al. Penetrating keratoplasty for perforated corneal ulcers under topical anesthesia. Cornea. 2013;32:1428–1431.
Sharma N, Jain M, Sehra SV, et al. Outcomes of therapeutic penetrating keratoplasty from a tertiary eye care centre in northern India. Cornea. 2014;33:114–118.
Shi W, Liu M, Gao H, et al. Penetrating keratoplasty with small-diameter and glycerin-cryopreserved grafts for eccentric corneal perforations. Cornea. 2009;28:631–637.
Yang JW, Lin HC, Hsiao CH, et al. Therapeutic penetrating keratoplasty in severe infective keratitis using glycerol-preserved donor corneas. Cornea. 2012;31:1103–1106.
Ogawa A, Yamaguchi T, Mitamura H, et al. Aetiology-specific comparison of long-term outcome of deep anterior lamellar keratoplasty for corneal diseases. Br J Ophthalmol. 2016;100:1176–1182.
Huang OS, Mehta JS, Htoon HM, et al. Incidence and risk factors of elevated intraocular pressure following deep anterior lamellar keratoplasty. Am J Ophthalmol. 2016;170:153–160.
Musa FU, Patil S, Rafiq O, et al. Long-term risk of intraocular pressure elevation and glaucoma escalation after deep anterior lamellar keratoplasty. Clin Exp Ophthalmol. 2012;40:780–785.
Deng SX, Borderie V, Chan CC, et al. Global consensus on definition, classification, diagnosis, and staging of limbal stem cell deficiency. Cornea. 2019;38:364–375.
Le Q, Xu J, Deng SX. The diagnosis of limbal stem cell deficiency. Ocul Surf. 2018;16:58–69.
Sacchetti M, Lambiase A. Diagnosis and management of neurotrophic keratitis. Clin Ophthalmol. 2014;8:571–579.
Yamaguchi T, Ohnuma K, Tomida D, et al. The contribution of the posterior surface to the corneal aberrations in eyes after keratoplasty. Invest Ophthalmol Vis Sci. 2011;52:6222–6229.
Myerscough J, Bovone C, Mimouni M, et al. Factors predictive of double anterior chamber formation following deep anterior lamellar keratoplasty. Am J Ophthalmol. 2019;205:11–16.
Dogan C, Arslan OS. Outcomes of therapeutic and tectonic penetrating keratoplasty in eyes with perforated infectious corneal ulcer. Turk J Ophthalmol. 2019;49:55–60.
Ti SE, Scott JA, Janardhanan P, et al. Therapeutic keratoplasty for advanced suppurative keratitis. Am J Ophthalmol. 2007;143:755–762.
Sharma N, Agarwal P, Titiyal JS, et al. Optimal use of donor corneal tissue: one cornea for two recipients. Cornea. 2011;30:1140–1144.

Auteurs

Takanori Suzuki (T)

Department of Ophthalmology, Tokyo Dental College Ichikawa General Hospital, Chiba, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH